KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$0.33.

  • Biogen's EPS (Basic) fell 11803.28% to -$0.33 in Q4 2025 from the same period last year, while for Dec 2025 it was $8.83, marking a year-over-year decrease of 2130.12%. This contributed to the annual value of $8.83 for FY2025, which is 2123.1% down from last year.
  • As of Q4 2025, Biogen's EPS (Basic) stood at -$0.33, which was down 11803.28% from $3.18 recorded in Q3 2025.
  • In the past 5 years, Biogen's EPS (Basic) ranged from a high of $7.86 in Q3 2022 and a low of -$0.68 during Q4 2021
  • For the 5-year period, Biogen's EPS (Basic) averaged around $2.82, with its median value being $2.7 (2021).
  • Per our database at Business Quant, Biogen's EPS (Basic) tumbled by 13102.0% in 2021 and then skyrocketed by 66808.51% in 2024.
  • Biogen's EPS (Basic) (Quarter) stood at -$0.68 in 2021, then surged by 664.03% to $3.85 in 2022, then tumbled by 55.29% to $1.72 in 2023, then grew by 6.4% to $1.83 in 2024, then crashed by 118.03% to -$0.33 in 2025.
  • Its EPS (Basic) stands at -$0.33 for Q4 2025, versus $3.18 for Q3 2025 and $4.33 for Q2 2025.